Key Points
-
Multiple sclerosis (MS) clusters with the so-called complex genetic diseases, a group of common disorders characterized by modest disease-risk heritability and multifaceted gene–environment interactions.
-
The genetic component of MS is reflected in the co-occurrence of cases within families and the high prevalence in some ethnic populations (particularly those of northern European origin) compared with others (African and Asian groups), irrespective of geographic location.
-
Concordance in families for early and late clinical features indicates that genes influence age of onset, disease course and other aspects of the clinical phenotype in addition to susceptibility.
-
The HLA-DRB1 gene on chromosome 6p21 is the strongest genetic factor identified as influencing MS susceptibility. However, recent studies suggest the possibility that complex trans-allelic interactions across the human leukocyte antigen (HLA) locus could determine the balance between susceptibility and resistance.
-
The power of genome-wide association (GWA) studies to isolate modest genetic variation associated with central nervous system autoimmunity was recently demonstrated with the confirmation of IL2R and IL7R as true MS disease genes.
-
Based on the allele-sharing date, common susceptibility alleles (that is, those with a frequency of >10%) are unlikely to increase the risk by more than a factor of 2.0. A 10,000–15,000 case GWA study would be a reasonable next step in the genetic analysis of MS.
-
Because of the redundancy and complexity inherent to the molecular, cellular and physiological pathways leading to disease, genetic studies in MS should move from the reductionist, single gene strategy to a multi-disciplinary, integrative and system-level research approach.
Abstract
Multiple sclerosis (MS) is an autoimmune demyelinating disease and a common cause of neurological disability in young adults. The modest heritability of MS reflects complex genetic effects and multifaceted gene–environment interactions. The human leukocyte antigen (HLA) region is the strongest susceptibility locus for MS, but a genome-wide association study recently identified new susceptibility genes. Progress in high-throughput genotyping and sequencing technologies and a better understanding of the structural organization of the human genome, together with powerful brain-imaging techniques that refine the phenotype, suggest that the tools could finally exist to identify the full set of genes influencing the pathogenesis of MS.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hauser, S. L. & Goodin, D. S. in Harrison's Principle of Internal Medicine 17th edn (eds Fauci, A. D. et al.) 2611–2620 (McGraw Hill, New York, 2008).
Hauser, S. L. & Oksenberg, J. R. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 52, 61–76 (2006).
Hemmer, B. & Hartung, H. P. Toward the development of rational therapies in multiple sclerosis: what is on the horizon? Ann. Neurol. 62, 314–326 (2007). This is an excellent review article that discusses the pipeline of therapeutic options and the challenges for multiple sclerosis.
Borden, E. C. et al. Interferons at age 50: past, current and future impact on biomedicine. Nature Rev. Drug Discov. 6, 975–990 (2007).
Weber, M. S., Hohlfeld, R. & Zamvil, S. S. Mechanism of action of glatiramer acetate in treatment of multiple sclerosis. Neurotherapeutics 4, 647–653 (2007).
International Multiple Sclerosis Genetics Consortium. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 357, 851–862 (2007). This paper presents the first GWA study performed in MS. It led to the identification of novel gene variants affecting susceptibility.
McCarthy, M. I. et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nature Rev. Genet. 9, 356–369 (2008).
Orton, S. M. et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol. 5, 932–936 (2006).
Ascherio, A. & Munger, K. L. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann. Neurol. 61, 288–299 (2007).
Ascherio, A. & Munger, K. L. Environmental risk factors for multiple sclerosis. Part II: noninfectious factors. Ann. Neurol. 61, 504–513 (2007).
Rosati, G. The prevalence of multiple sclerosis in the world: an update. Neurol. Sci. 22, 117–139 (2001).
Sotgiu, S., Pugliatti, M., Sotgiu, A., Sanna, A. & Rosati, G. Does the 'hygiene hypothesis' provide an explanation for the high prevalence of multiple sclerosis in Sardinia? Autoimmunity 36, 257–260 (2003).
Pugliatti, M., Sotgiu, S. & Rosati, G. The worldwide prevalence of multiple sclerosis. Clin. Neurol. Neurosurg. 104, 182–191 (2002).
Islam, T., Gauderman, W. J., Cozen, W. & Mack, T. M. Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins. Neurology 69, 381–388 (2007).
Freedman, D. M., Dosemeci, M. & Alavanja, M. C. Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case–control study based on death certificates. Occup. Environ. Med. 57, 418–421 (2000).
Lipton, H. L., Liang, Z., Hertzler, S. & Son, K. N. A specific viral cause of multiple sclerosis: one virus, one disease. Ann. Neurol. 61, 514–523 (2007).
Ascherio, A. et al. Epstein–Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 286, 3083–3088 (2001).
Cepok, S. et al. Identification of Epstein–Barr virus proteins as putative targets of the immune response in multiple sclerosis. J. Clin. Invest. 115, 1352–1360 (2005).
Levin, L. I. et al. Temporal relationship between elevation of Epstein–Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 293, 2496–2500 (2005).
Serafini, B. et al. Dysregulated Epstein–Barr virus infection in the multiple sclerosis brain. J. Exp. Med. 204, 2899–2912 (2007). This paper presents strong evidence for a role of EBV in MS susceptibility. The virus seems to gain access to the white matter within B-cells that infiltrate the meninges.
Hauser, S. L. et al. B-cell depletion with rituximab in relapsing–remitting multiple sclerosis. N. Engl. J. Med. 358, 676–688 (2008).
Schmidt, S. et al. Allelic association of sequence variants in the herpesvirus entry mediator-B gene (PVRL2) with the severity of multiple sclerosis. Genes Immun. 7, 384–392 (2006).
Risch, N. Linkage strategies for genetically complex traits. I. Multilocus models. Am. J. Hum. Genet. 46, 222–228 (1990).
Sadovnick, A. D. Familial recurrence risks and inheritance of multiple sclerosis. Curr. Opin. Neurol. Neurosurg. 6, 189–194 (1993).
Robertson, N. P. et al. Age-adjusted recurrence risks for relatives of patients with multiple sclerosis. Brain 119, 449–455 (1996).
Carton, H. et al. Risks of multiple sclerosis in relatives of patients in Flanders, Belgium. J. Neurol. Neurosurg. Psychiatry 62, 329–333 (1997).
Ebers, G. C., Sadovnick, A. D. & Risch, N. J. A genetic basis for familial aggregation in multiple sclerosis. Nature 377, 150–151 (1995).
Sadovnick, A. D., Ebers, G. C., Dyment, D. A., Risch, N. J. Evidence for genetic basis of multiple sclerosis. Lancet 347, 1728–1730 (1996).
Ebers, G. C., Yee, I. M., Sadovnick, A. D. & Duquette, P. Conjugal multiple sclerosis: population-based prevalence and recurrence risks in offspring. Ann. Neurol. 48, 927–931 (2000).
Willer, C. J. et al. Timing of birth and risk of multiple sclerosis: population based study. BMJ 330, 120 (2005).
Hupperts, R. et al. Patterns of disease in concordant parent–child pairs with multiple sclerosis. Neurology 57, 290–295 (2001).
Ebers, G. C. et al. Parent-of-origin effect in multiple sclerosis: observations in half-siblings. Lancet 363, 1773–1774 (2004).
Kantarci, O. H. et al. Men with MS transmit the disease more often to their children then women: the Carter effect. Mult. Scler. 10, S203 (2004).
Brassat, D. et al. Familial factors influence disability in MS multiplex families. Neurology 52, 1632–1636 (1999).
Barcellos, L. F. et al. Genetic basis for clinical expression in multiple sclerosis. Brain 125, 150–158 (2002).
Hensiek, A. E. et al. Familial effects on the clinical course of multiple sclerosis. Neurology 68, 376–383 (2007).
Deluca, G. C. et al. An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus. Proc. Natl Acad. Sci. USA 104, 20896–20901 (2007).
Mumford, C. J., et al. The British Isles survey of multiple sclerosis in twins. Neurology 44, 11–15 (1994).
Willer, C. J., Dyment, D. A., Risch, N. J., Sadovnick, A. D. & Ebers, G. C. Twin concordance and sibling recurrence rates in multiple sclerosis. Proc. Natl Acad. Sci. USA 100, 12877–12882 (2003).
Hansen, T. et al. Concordance for multiple sclerosis in Danish twins: an update of a nationwide study. Mult. Scler. 11, 504–510 (2005).
Islam, T. et al. Differential twin concordance for multiple sclerosis by latitude of birthplace. Ann. Neurol. 60, 56–64 (2006). This paper describes an elegant epidemiological study in twins that demonstrates the confluent role of genes and environment in MS susceptibility.
Ioannidis, J. P., Trikalinos, T. A. & Khoury, M. J. Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases. Am. J. Epidemiol. 164, 609–614 (2006).
Ioannidis, J. P., Trikalinos, T. A., Ntzani, E. E. & Contopoulos-Ioannidis, D. G. Genetic associations in large versus small studies: an empirical assessment. Lancet 361, 567–571 (2003).
Yang, Q., Khoury, M. J., Friedman, J., Little, J. & Flanders, W. D. How many genes underlie the occurrence of common complex diseases in the population? Int. J. Epidemiol. 34, 1129–1137 (2005).
Wang, W. Y., Barratt, B. J., Clayton, D. G. & Todd, J. A. Genome-wide association studies: theoretical and practical concerns. Nature Rev. Genet. 6, 109–118 (2005).
Lennon, V. A. et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364, 2106–2112 (2004). This paper gives compelling evidence for the presence of true heterogeneity in human autoimmune demyelinating disease, leading to the discovery of anti-aquaporin 4 antibodies as a biomarker of neuromyelitis optica (Devic syndrome).
Confavreux, C. & Vukusic, S. Natural history of multiple sclerosis: a unifying concept. Brain 129, 606–616 (2006).
Corder, E. H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921–923 (1993).
Horikawa, Y. et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nature Genet. 26, 163–175 (2000).
Hugot, J. P. et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599–603 (2001).
Ogura, Y. et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603–606 (2001).
Stefansson, H. et al. Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 71, 877–892 (2002).
Fernald, G. H., Yeh, R. F., Hauser, S. L., Oksenberg, J. R. & Baranzini, S. E. Mapping gene activity in complex disorders: integration of expression and genomic scans for multiple sclerosis. J. Neuroimmunol. 167, 157–169 (2005).
Haines, J. L. et al. Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. Hum. Mol. Genet. 7, 1229–1234 (1998).
Sawcer, S. et al. A high-density screen for linkage in multiple sclerosis. Am. J. Hum. Genet. 77, 454–467 (2005).
Risch, N. & Merikangas, K. The future of genetic studies of complex human diseases. Science 273, 1516–1517 (1996). This paper presents an influential analysis demonstrating the power of association analysis for gene discovery in complex human diseases.
Compston, D. A., Batchelor, J. R. & McDonald, W. I. B-lymphocyte alloantigens associated with multiple sclerosis. Lancet 2, 1261–1265 (1976).
Olerup, O. & Hillert, J. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens 38, 1–15 (1991).
Hirschhorn, J. N., Lohmueller, K., Byrne, E. & Hirschhorn, K. A comprehensive review of genetic association studies. Genet. Med. 4, 45–61 (2002).
Burton, P. R. et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nature Genet. 39, 1329–1337 (2007).
McDonnell, G. V., Mawhinney, H., Graham, C. A., Hawkins, S. A. & Middleton, D. A study of the HLA-DR region in clinical subgroups of multiple sclerosis and its influence on prognosis. J. Neurol. Sci. 165, 77–83 (1999).
Barcellos, L. F. et al. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum. Mol. Genet. 15, 2813–2824 (2006).
Barcellos, L. F. et al. HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am. J. Hum. Genet. 72, 710–716 (2003).
Miretti, M. M. et al. A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms. Am. J. Hum. Genet. 76, 634–646 (2005).
Fukazawa, T. et al. Genomic HLA profiles of MS in Hokkaido, Japan: important role of DPB1*0501 allele. J. Neurol. 247, 175–178 (2000).
Fernandez, O. et al. DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain. J. Neurol. 251, 440–444 (2004).
Lincoln, M. R. et al. A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nature Genet. 37, 1108–1112 (2005).
Prat, E. et al. HLA-DRB5*0101 and -DRB1*1501 expression in the multiple sclerosis-associated HLA-DR15 haplotype. J. Neuroimmunol 167, 108–119 (2005).
Sospedra, M. et al. Redundancy in antigen-presenting function of the HLA-DR and -DQ molecules in the multiple sclerosis-associated HLA-DR2 haplotype. J. Immunol. 176, 1951–1961 (2006).
de Jong, B. A. et al. Evidence for additional genetic risk indicators of relapse-onset MS within the HLA region. Neurology 59, 549–555 (2002).
Marrosu, M. G. et al. Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia. Hum. Mol. Genet. 10, 2907–2916 (2001).
Fogdell-Hahn, A., Ligers, A., Gronning, M., Hillert, J. & Olerup, O. Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens 55, 140–148 (2000).
Rubio, J. P. et al. Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis. Am. J. Hum. Genet. 70, 1125–1137 (2002).
Yeo, T. W. et al. A second major histocompatibility complex susceptibility locus for multiple sclerosis. Ann. Neurol. 61, 228–236 (2007).
Wallin, M. T., Page, W. F. & Kurtzke, J. F. Multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex, and geography. Ann. Neurol. 55, 65–71 (2004).
Cree, B. A. et al. Clinical characteristics of African Americans versus Caucasian Americans with multiple sclerosis. Neurology 63, 2039–2045 (2004).
Oksenberg, J. R. et al. Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am. J. Hum. Genet. 74, 160–167 (2004). This is a comprehensive analysis of HLA-DRB1 and HLA-DQB1 alleles and haplotypes in an African American MS cohort showing a selective genetic association with HLA-DRB1 . This work establishes the centromeric boundary of the HLA-class II DR – DQ association and suggests a primary role for the HLA-DRB1 gene in MS susceptibility that is independent of HLA-DQB1.
Patterson, N. et al. Methods for high-density admixture mapping of disease genes. Am. J. Hum. Genet. 74, 979–1000 (2004).
Seldin, M. F. et al. Putative ancestral origins of chromosomal segments in individual African Americans: implications for admixture mapping. Genome Res. 14, 1076–1084 (2004).
Reich, D. et al. A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility. Nature Genet. 37, 1113–1118 (2005). This paper describes the first all-genome admixture scan in 605 African-American MS cases and 1,043 African-American controls, and reports a locus on chromosome 1 near the centromere that is associated with MS.
Stratmann, T. et al. Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity. J. Clin. Invest. 112, 902–914 (2003).
Wucherpfennig, K. W. The structural interactions between T cell receptors and MHC-peptide complexes place physical limits on self–nonself discrimination. Curr. Top. Microbiol. Immunol. 296, 19–37 (2005).
Smith, K. J., Pyrdol, J., Gauthier, L., Wiley, D. C. & Wucherpfennig, K. W. Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein. J. Exp. Med. 188, 1511–1520 (1998). This structural analysis of HLA-peptide crystals provides important mechanistic insights associated with the autoimmune response in MS.
Rasmussen, H. B., Kelly, M. A. & Clausen, J. Additive effect of the HLA-DR15 haplotype on susceptibility to multiple sclerosis. Mult. Scler. 7, 91–93 (2001).
Dyment, D. A. et al. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum. Mol. Genet. 14, 2019–2026 (2005). This work underscores the importance of using a large sample size to detect the complex genetic effects of relevance to MS that are embedded in the HLA locus.
Ramagopalan, S. V. et al. The inheritance of resistance alleles in multiple sclerosis. PLoS Genet. 3, 1607–1613 (2007).
Khare, M., Mangalam, A., Rodriguez, M. & David, C. S. HLA DR and DQ interaction in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in HLA class II transgenic mice. J. Neuroimmunol 169, 1–12 (2005).
Mangalam, A. et al. HLA-DQ6 (DQB1*0601)-restricted T cells protect against experimental autoimmune encephalomyelitis in HLA-DR.DQ6 double transgenic mice by generating anti-inflammatory IFN gamma. J. Immunol. 180, 7747–7756 (2008).
Gregersen, J. W. et al. Functional epistasis on a common MHC haplotype associated with multiple sclerosis. Nature 443, 574–577 (2006). In this paper, experimental autoimmune encephalomyelitis data using triple DRB1/DRB5/hTCR transgenic mice demonstrate epistasis within the MHC and strongly favour a disease-modifying effect for DRB5.
Sundvall, M. et al. Identification of murine loci associated with susceptibility to chronic experimental encephalomyelitis. Nature Genet. 10, 313–317 (1995).
Ramanathan, M. et al. In vivo gene expression revealed by cDNA arrays: the pattern in relapsing–remitting multiple sclerosis patients compared with normal subjects. J. Neuroimmunol. 116, 213–219 (2001).
Bomprezzi, R. et al. Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. Hum. Mol. Genet. 12, 2191–2199 (2003).
Teutsch, S. M., Booth, D. R., Bennetts, B. H., Heard, R. N. & Stewart, G. J. Identification of 11 novel and common single nucleotide polymorphisms in the interleukin-7 receptor-alpha gene and their associations with multiple sclerosis. Eur. J. Hum. Genet. 11, 509–515 (2003).
Zhang, Z. et al. Two genes encoding immune-regulatory molecules (LAG3 and IL7R) confer susceptibility to multiple sclerosis. Genes Immun. 6, 145–152 (2005).
Gregory, S. G. et al. Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nature Genet. 39, 1083–1091 (2007). This paper presents a genetic and molecular demonstration of the role of the IL7R gene in MS susceptibility.
Lundmark, F. et al. Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nature Genet. 39, 1108–1113 (2007).
McKay, F. C. et al. Haplotypes of the interleukin 7 receptor alpha gene are correlated with altered expression in whole blood cells in multiple sclerosis. Genes Immun. 9, 1–6 (2008).
Mazzucchelli, R. & Durum, S. K. Interleukin-7 receptor expression: intelligent design. Nature Rev. Immunol. 7, 144–154 (2007).
Ramagopalan, S. V., Anderson, C., Sadovnick, A. D. & Ebers, G. E. Genome wide study of multiple sclerosis. N. Engl. J. Med. 357, 2199–2100 (2007).
Maier, L. M. & Hafler, D. A. The developing mosaic of autoimmune disease risk. Nature Genet. 40, 131–132 (2008).
Lock, C. et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nature Med. 8, 500–508 (2002).
Lindberg, R. L. et al. Multiple sclerosis as a generalized CNS disease — comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS. J. Neuroimmunol. 152, 154–167 (2004).
Dutta, R. et al. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann. Neurol. 59, 478–489 (2006).
Comabella, M. & Martin, R. Genomics in multiple sclerosis. Current state and future directions. J. Neuroimmunol. 187, 1–8 (2007).
McElroy, J. P. & Oksenberg, J. R. Multiple sclerosis genetics. Curr. Top. Microbiol. Immunol. 318, 45–72 (2008).
Baranzini, S. E. Gene expression profiling in neurological disorders: toward a systems-level understanding of the brain. Neuromolecular Med. 6, 31–52 (2004).
Baranzini, S. E., Bernard, C. C. & Oksenberg, J. R. Modular transcriptional activity characterizes the initiation and progression of autoimmune encephalomyelitis. J. Immunol. 174, 7412–7422 (2005).
Otaegui, D. et al. Increased transcriptional activity of milk-related genes following the active phase of experimental autoimmune encephalomyelitis and multiple sclerosis. J. Immunol. 179, 4074–4082 (2007).
Satoh, J. et al. Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis. Neurobiol. Dis. 18, 537–550 (2005).
Baranzini, S. E. et al. Transcription-based prediction of response to IFNbeta using supervised computational methods. PLoS Biol. 3, e2 (2005).
Achiron, A., Feldman, A., Mandel, M. & Gurevich, M. Impaired expression of peripheral blood apoptotic-related gene transcripts in acute multiple sclerosis relapse. Ann. N. Y. Acad. Sci. 1107, 155–167 (2007).
Cheung, V. G. et al. Natural variation in human gene expression assessed in lymphoblastoid cells. Nature Genet. 33, 422–425 (2003).
Chesler, E. J. et al. Complex trait analysis of gene expression uncovers polygenic and pleiotropic networks that modulate nervous system function. Nature Genet. 37, 233–242 (2005).
Stranger, B. E. et al. Population genomics of human gene expression. Nature Genet. 39, 1217–1224 (2007).
Byun, E. et al. Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis. Arch. Neurol. 65, 337–344 (2008).
Kruglyak, L. & Nickerson, D. A. Variation is the spice of life. Nature Genet. 27, 234–236 (2001).
Wacholder, S., Chanock, S., Garcia-Closas, M., El Ghormli, L. & Rothman, N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J. Natl Cancer Inst. 96, 434–442 (2004).
Steinam, L. & Zamvil, S. S. How to successfully apply animal studies in experimental allergic encephalomyelitis to research multiple sclerosis. Ann. Neurol. 60, 12–21 (2006).
Blankenhorn, E. P. et al. Genetic analysis of the influence of pertussis toxin on experimental allergic encephalomyelitis susceptibility: an environmental agent can override genetic checkpoints. J. Immunol. 164, 3420–3425 (2000).
Teuscher C. et al. Gender, age, and season at immunization uniquely influence the genetic control of susceptibility to histopathological lesions and clinical signs of experimental allergic encephalomyelitis: implications for the genetics of multiple sclerosis. Am. J. Hum. Pathol. 165, 1593–1602 (2004). This work presents an interesting study design that allows the influence of genetic and non-genetic factors involved in the induction of encephalomyelitis to be modelled.
Anderson, A. & Karlsson J. Genetic of experimental autoimmune encephalomyelitis in the mouse. Arch. Immunol. Ther. Exp. (Warz) 52, 316–325 (2004).
Olsson, T. & Hillert J. The genetics of multiple sclerosis and its experimental models. Curr. Opin Neurol. 21, 255–260 (2008).
Tesucher C. et al. Evidence that the Y chromosome influences autoimmune disease in male and female mice. Proc. Natl Acad. Sci. USA 21, 8024–8029 (2006).
Bieber, A. J. Ure, D. R. & Rodriguez, M. Genetically dominant spinal cord repair in a murine model of chronic progressive multiple sclerosis. J. Neuropathol. Exp. Neurol. 64, 46–57 (2005).
Barabasi, A. L. & Oltvai, Z. N. Network biology: understanding the cell's functional organization. Nature Rev. Genet. 5, 101–113 (2004).
Acknowledgements
The concepts and discussion presented in this paper reflect the interactions with our IMSGC colleagues. The authors are supported by the US and UK Multiple Sclerosis Societies, the National Institute of Health, the Wellcome Trust, and the Nancy Davis Foundation. We especially thank the many MS patients and their families who participated in our studies.
Author information
Authors and Affiliations
Corresponding authors
Related links
Related links
DATABASES
OMIM
FURTHER INFORMATION
Immunogenetics (IMGT) database
Glossary
- Heritability
-
The proportion of the total phenotypic variation for a given characteristic in a population that can be attributed to genetic variance among individuals.
- Heterogeneity
-
Allelic heterogeneity refers to the situation in which more than one allele from a gene is associated with a given disease, whereas genetic or locus heterogeneity refers to the situation in which variation in different genes might cause identical or similar forms of the disease in different subjects.
- Viraemia
-
The presence of a virus in the bloodstream.
- Oligoclonal
-
Oligoclonal bands are distinct immunoglobulin G bands detected by protein electrophoresis in the cerebrospinal fluid of most MS patients
- Clonotype
-
Homogeneous group of cells of the immune system that share antigen receptors and antigen specificity.
- Devic syndrome
-
Neuromyelitis optica (NMO; Devic syndrome) is characterized by separate attacks of acute optic neuritis and myelitis. Anti-aquaporin 4 antibodies in the serum are a biomarker for NMO. Whether NMO is a variant of MS or a distinct disease is uncertain.
- Microsatellites
-
Short, polymorphic sequences of DNA repeated in tandem. Typically co-dominant, microsatellites are useful genetic markers with wide-ranging applications in disease, population and forensic studies.
- LOD score
-
The logarithm (base 10) of the likelihood ratio (odds). The LOD score serves as a test of the null hypothesis of free recombination versus the alternative hypothesis of linkage.
- Type I error
-
The probability of rejecting the null hypothesis when it is true. For association studies, type I errors are manifest as false-positive reports of phenotype–genotype correlation.
- Linkage disequilibrium
-
(LD). The condition in which the frequency of a particular haplotype for two loci is significantly different from that expected if the loci were assorting independently.
- Positive selection
-
The process by which new advantageous genetic variants become more common in a population.
- Prior odds
-
Refers to the odds that a test hypothesis is true as compared with the null hypothesis before any experiment is undertaken. Prior odds can be derived from first principles, or based on general knowledge or previous experiments.
- Posterior odds
-
Refers to the odds that a test hypothesis is true as compared with the null hypothesis after an experiment is completed; that is, in light of the new data provided by the experiment. If an experiment is well powered and the test hypothesis is true, then the expectation is that the posterior odds will be greater than the prior odds.
- Bayesian approach
-
A statistical school of thought that, in contrast to the frequentist school, holds that inferences about any unknown parameter or hypothesis should be encapsulated in a probability distribution, given the observed data. Bayes' theorem is a celebrated result in probability theory that allows the computation of the posterior distribution for an unknown from the observed data and its assumed distribution before experiment.
- Admixture mapping
-
Efficient approach to map disease-causing variants that differ in frequency (owing to either drift or selection) between two historically separated populations.
- Negative selection
-
In immunology, the central tolerance that occurs during early T cell development in the thymus that causes cells with strong reactivity to self-antigens to undergo apoptosis and elimination. Cells with antigen-specific receptors that would enable them to respond efficiently to foreign peptides in association with self-MHC proteins survive, mature, and migrate to peripheral lymphoid organs.
- Encephalitogenic cell
-
Lymphocyte of the T lineage that is capable of homing into the CNS from peripheral lymphoid compartments and mediating a damaging inflammatory process.
- Tag-SNP
-
Representative SNP in a region of high LD used to identify short haplotypes.
- Real-time quantitative PCR
-
Fluorescence-based enzymatic amplification method to quantify with high sensitivity gene expression levels, following reverse transcription (RT) of mRNA into complementary DNA (cDNA).
Rights and permissions
About this article
Cite this article
Oksenberg, J., Baranzini, S., Sawcer, S. et al. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat Rev Genet 9, 516–526 (2008). https://doi.org/10.1038/nrg2395
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrg2395
This article is cited by
-
The Role of Gut Dysbiosis and Potential Approaches to Target the Gut Microbiota in Multiple Sclerosis
CNS Drugs (2023)
-
Vitamins A and D Enhance the Expression of Ror-γ-Targeting miRNAs in a Mouse Model of Multiple Sclerosis
Molecular Neurobiology (2023)
-
An investigation of genetic polymorphisms in heparan sulfate proteoglycan core proteins and key modification enzymes in an Australian Caucasian multiple sclerosis population
Human Genomics (2020)
-
Association Between IL7R Promoter Polymorphisms and Multiple Sclerosis in Turkish Population
Journal of Molecular Neuroscience (2019)
-
Immune-cell crosstalk in multiple sclerosis
Nature (2018)